PRION INDUCED DISORDERS
\pɹˈa͡ɪɒn ɪndjˈuːst dɪsˈɔːdəz], \pɹˈaɪɒn ɪndjˈuːst dɪsˈɔːdəz], \p_ɹ_ˈaɪ_ɒ_n ɪ_n_d_j_ˈuː_s_t d_ɪ_s_ˈɔː_d_ə_z]\
Sort: Oldest first
-
A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA, ataxia, and a fatal outcome. Diseases in this category include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER-SCHEINKER SYNDROME; KURU; SCRAPIE; fatal familial insomnia; bovine spongiform encephalopathy (see ENCEPHALOPATHY, BOVINE SPONGIFORM); transmissible mink encephalopathy; and chronic wasting disease of mule deer and elk. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95 (23):13363-83)
By DataStellar Co., Ltd
Word of the day
Colony Stimulating Factor 1
- mononuclear phagocyte factor (CSF) synthesized by mesenchymal cells. The compound stimulates survival, proliferation, and differentiation hematopoietic cells monocyte-series. M-CSF is a disulfide-bonded glycoprotein dimer with MW of 70 kDa. It binds to specific high affinity receptor (RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR).